BAKKAFROST P/F (BAKKA.OL) Fundamental Analysis & Valuation

OSL:BAKKAFO0000000179

Current stock price

464.2 NOK
-9.2 (-1.94%)
Last:

This BAKKA.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. BAKKA.OL Profitability Analysis

1.1 Basic Checks

  • BAKKA had positive earnings in the past year.
  • In the past year BAKKA had a positive cash flow from operations.
  • BAKKA had positive earnings in each of the past 5 years.
  • BAKKA had a positive operating cash flow in each of the past 5 years.
BAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFBAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B -2B -3B

1.2 Ratios

  • BAKKA's Return On Assets of 2.80% is in line compared to the rest of the industry. BAKKA outperforms 43.10% of its industry peers.
  • With a Return On Equity value of 4.83%, BAKKA is not doing good in the industry: 60.34% of the companies in the same industry are doing better.
  • With a Return On Invested Capital value of 3.10%, BAKKA is not doing good in the industry: 72.41% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for BAKKA is in line with the industry average of 7.16%.
Industry RankSector Rank
ROA 2.8%
ROE 4.83%
ROIC 3.1%
ROA(3y)3.95%
ROA(5y)5.28%
ROE(3y)6.49%
ROE(5y)8.55%
ROIC(3y)5.25%
ROIC(5y)5.4%
BAKKA.OL Yearly ROA, ROE, ROICBAKKA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 7.61%, BAKKA is in the better half of the industry, outperforming 70.69% of the companies in the same industry.
  • BAKKA's Profit Margin has declined in the last couple of years.
  • BAKKA's Operating Margin of 10.19% is fine compared to the rest of the industry. BAKKA outperforms 68.97% of its industry peers.
  • BAKKA's Operating Margin has declined in the last couple of years.
  • BAKKA's Gross Margin of 67.75% is amongst the best of the industry. BAKKA outperforms 96.55% of its industry peers.
  • In the last couple of years the Gross Margin of BAKKA has grown nicely.
Industry RankSector Rank
OM 10.19%
PM (TTM) 7.61%
GM 67.75%
OM growth 3Y-21.27%
OM growth 5Y-3.56%
PM growth 3Y-26.25%
PM growth 5Y-5.33%
GM growth 3Y-1.41%
GM growth 5Y3.18%
BAKKA.OL Yearly Profit, Operating, Gross MarginsBAKKA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. BAKKA.OL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BAKKA is destroying value.
  • BAKKA has about the same amout of shares outstanding than it did 1 year ago.
  • BAKKA has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BAKKA has a worse debt to assets ratio.
BAKKA.OL Yearly Shares OutstandingBAKKA.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
BAKKA.OL Yearly Total Debt VS Total AssetsBAKKA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.66 indicates that BAKKA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.66, BAKKA is in the better half of the industry, outperforming 68.97% of the companies in the same industry.
  • A Debt/Equity ratio of 0.45 indicates that BAKKA is not too dependend on debt financing.
  • BAKKA has a better Debt to Equity ratio (0.45) than 62.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 2.66
ROIC/WACC0.37
WACC8.27%
BAKKA.OL Yearly LT Debt VS Equity VS FCFBAKKA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • BAKKA has a Current Ratio of 6.66. This indicates that BAKKA is financially healthy and has no problem in meeting its short term obligations.
  • BAKKA's Current ratio of 6.66 is amongst the best of the industry. BAKKA outperforms 100.00% of its industry peers.
  • BAKKA has a Quick Ratio of 1.57. This is a normal value and indicates that BAKKA is financially healthy and should not expect problems in meeting its short term obligations.
  • BAKKA's Quick ratio of 1.57 is amongst the best of the industry. BAKKA outperforms 82.76% of its industry peers.
Industry RankSector Rank
Current Ratio 6.66
Quick Ratio 1.57
BAKKA.OL Yearly Current Assets VS Current LiabilitesBAKKA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

6

3. BAKKA.OL Growth Analysis

3.1 Past

  • The earnings per share for BAKKA have decreased strongly by -62.66% in the last year.
  • BAKKA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.17% yearly.
  • BAKKA shows a decrease in Revenue. In the last year, the revenue decreased by -4.45%.
  • Measured over the past years, BAKKA shows a quite strong growth in Revenue. The Revenue has been growing by 8.54% on average per year.
EPS 1Y (TTM)-62.66%
EPS 3Y-28.71%
EPS 5Y2.17%
EPS Q2Q%-40.5%
Revenue 1Y (TTM)-4.45%
Revenue growth 3Y-0.58%
Revenue growth 5Y8.54%
Sales Q2Q%25.66%

3.2 Future

  • Based on estimates for the next years, BAKKA will show a very strong growth in Earnings Per Share. The EPS will grow by 63.74% on average per year.
  • BAKKA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.92% yearly.
EPS Next Y174.18%
EPS Next 2Y95.95%
EPS Next 3Y63.74%
EPS Next 5YN/A
Revenue Next Year16.1%
Revenue Next 2Y15.26%
Revenue Next 3Y14.92%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BAKKA.OL Yearly Revenue VS EstimatesBAKKA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
BAKKA.OL Yearly EPS VS EstimatesBAKKA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

3

4. BAKKA.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • BAKKA is valuated quite expensively with a Price/Earnings ratio of 45.29.
  • 68.97% of the companies in the same industry are cheaper than BAKKA, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of BAKKA to the average of the S&P500 Index (26.86), we can say BAKKA is valued expensively.
  • BAKKA is valuated correctly with a Price/Forward Earnings ratio of 16.52.
  • BAKKA's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 37.39. BAKKA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 45.29
Fwd PE 16.52
BAKKA.OL Price Earnings VS Forward Price EarningsBAKKA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 67.24% of the companies in the same industry are cheaper than BAKKA, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.77
BAKKA.OL Per share dataBAKKA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

  • BAKKA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BAKKA's earnings are expected to grow with 63.74% in the coming years.
PEG (NY)0.26
PEG (5Y)20.91
EPS Next 2Y95.95%
EPS Next 3Y63.74%

3

5. BAKKA.OL Dividend Analysis

5.1 Amount

  • BAKKA has a Yearly Dividend Yield of 2.81%.
  • BAKKA's Dividend Yield is a higher than the industry average which is at 2.60.
  • Compared to an average S&P500 Dividend Yield of 1.82, BAKKA pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.81%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • BAKKA pays out 93.91% of its income as dividend. This is not a sustainable payout ratio.
DP93.91%
EPS Next 2Y95.95%
EPS Next 3Y63.74%
BAKKA.OL Yearly Income VS Free CF VS DividendBAKKA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B
BAKKA.OL Dividend Payout.BAKKA.OL Dividend Payout, showing the Payout Ratio.BAKKA.OL Dividend Payout.PayoutRetained Earnings

BAKKA.OL Fundamentals: All Metrics, Ratios and Statistics

BAKKAFROST P/F

OSL:BAKKA (4/13/2026, 4:19:50 PM)

464.2

-9.2 (-1.94%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-02
Earnings (Next)N/A
Inst Owners59.55%
Inst Owner ChangeN/A
Ins Owners16.08%
Ins Owner ChangeN/A
Market Cap27.57B
Revenue(TTM)7.01B
Net Income(TTM)532.99M
Analysts77.89
Price Target519.52 (11.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.81%
Yearly Dividend12.56
Dividend Growth(5Y)N/A
DP93.91%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-62.53%
Min EPS beat(2)-100%
Max EPS beat(2)-25.05%
EPS beat(4)0
Avg EPS beat(4)-61.47%
Min EPS beat(4)-106.11%
Max EPS beat(4)-14.72%
EPS beat(8)1
Avg EPS beat(8)-40.19%
EPS beat(12)3
Avg EPS beat(12)-28.72%
EPS beat(16)3
Avg EPS beat(16)-26.21%
Revenue beat(2)0
Avg Revenue beat(2)-14.59%
Min Revenue beat(2)-17.55%
Max Revenue beat(2)-11.63%
Revenue beat(4)0
Avg Revenue beat(4)-15.9%
Min Revenue beat(4)-21.74%
Max Revenue beat(4)-11.63%
Revenue beat(8)1
Avg Revenue beat(8)-12.62%
Revenue beat(12)2
Avg Revenue beat(12)-8.17%
Revenue beat(16)5
Avg Revenue beat(16)-6%
PT rev (1m)2%
PT rev (3m)-5.77%
EPS NQ rev (1m)2.37%
EPS NQ rev (3m)-17.76%
EPS NY rev (1m)2%
EPS NY rev (3m)-10.34%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-8.91%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)-3.6%
Valuation
Industry RankSector Rank
PE 45.29
Fwd PE 16.52
P/S 2.64
P/FCF N/A
P/OCF 17.18
P/B 1.68
P/tB 2.84
EV/EBITDA 15.77
EPS(TTM)10.25
EY2.21%
EPS(NY)28.1
Fwd EY6.05%
FCF(TTM)-1.42
FCFYN/A
OCF(TTM)27.02
OCFY5.82%
SpS175.52
BVpS276.59
TBVpS163.64
PEG (NY)0.26
PEG (5Y)20.91
Graham Number252.56
Profitability
Industry RankSector Rank
ROA 2.8%
ROE 4.83%
ROCE 3.92%
ROIC 3.1%
ROICexc 3.15%
ROICexgc 4.21%
OM 10.19%
PM (TTM) 7.61%
GM 67.75%
FCFM N/A
ROA(3y)3.95%
ROA(5y)5.28%
ROE(3y)6.49%
ROE(5y)8.55%
ROIC(3y)5.25%
ROIC(5y)5.4%
ROICexc(3y)5.38%
ROICexc(5y)5.58%
ROICexgc(3y)7.36%
ROICexgc(5y)7.83%
ROCE(3y)6.64%
ROCE(5y)6.83%
ROICexgc growth 3Y-27.3%
ROICexgc growth 5Y-6.84%
ROICexc growth 3Y-25.81%
ROICexc growth 5Y-3.42%
OM growth 3Y-21.27%
OM growth 5Y-3.56%
PM growth 3Y-26.25%
PM growth 5Y-5.33%
GM growth 3Y-1.41%
GM growth 5Y3.18%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 3.33
Cap/Depr 144.57%
Cap/Sales 16.2%
Interest Coverage 250
Cash Conversion 71.96%
Profit Quality N/A
Current Ratio 6.66
Quick Ratio 1.57
Altman-Z 2.66
F-Score3
WACC8.27%
ROIC/WACC0.37
Cap/Depr(3y)152.36%
Cap/Depr(5y)179.46%
Cap/Sales(3y)15.02%
Cap/Sales(5y)16.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-62.66%
EPS 3Y-28.71%
EPS 5Y2.17%
EPS Q2Q%-40.5%
EPS Next Y174.18%
EPS Next 2Y95.95%
EPS Next 3Y63.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.45%
Revenue growth 3Y-0.58%
Revenue growth 5Y8.54%
Sales Q2Q%25.66%
Revenue Next Year16.1%
Revenue Next 2Y15.26%
Revenue Next 3Y14.92%
Revenue Next 5YN/A
EBIT growth 1Y-46.25%
EBIT growth 3Y-21.72%
EBIT growth 5Y4.67%
EBIT Next Year213.85%
EBIT Next 3Y62.56%
EBIT Next 5YN/A
FCF growth 1Y-104.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.2%
OCF growth 3Y-3.54%
OCF growth 5Y17.87%

BAKKAFROST P/F / BAKKA.OL Fundamental Analysis FAQ

What is the fundamental rating for BAKKA stock?

ChartMill assigns a fundamental rating of 5 / 10 to BAKKA.OL.


Can you provide the valuation status for BAKKAFROST P/F?

ChartMill assigns a valuation rating of 3 / 10 to BAKKAFROST P/F (BAKKA.OL). This can be considered as Overvalued.


Can you provide the profitability details for BAKKAFROST P/F?

BAKKAFROST P/F (BAKKA.OL) has a profitability rating of 5 / 10.


Can you provide the financial health for BAKKA stock?

The financial health rating of BAKKAFROST P/F (BAKKA.OL) is 4 / 10.


Is the dividend of BAKKAFROST P/F sustainable?

The dividend rating of BAKKAFROST P/F (BAKKA.OL) is 3 / 10 and the dividend payout ratio is 93.91%.